Phibro Animal Health (PAHC) Raw Materials (2013 - 2026)

Phibro Animal Health's Raw Materials history runs 14 years deep, the most recent figure standing at $191.7 million for Q1 2026.

• On a quarterly basis, Raw Materials rose 27.13% year-over-year to $191.7 million in Q1 2026; TTM through Mar 2026 was $191.7 million, a 27.13% increase from a year earlier, with the FY2025 full-year figure at $162.6 million, up 123.39% from the prior year.
• Raw Materials grew to $191.7 million in Q1 2026 per PAHC's latest filing, from $178.5 million in the prior quarter.
• Across five years, Raw Materials topped out at $191.7 million in Q1 2026 and bottomed at $72.8 million in Q2 2024.
• The 5-year median for Raw Materials is $87.0 million (2022), against an average of $112.8 million.
• Across the five-year window, Raw Materials decreased 20.21% in 2023 and soared 123.39% in 2025, its largest moves.
• Year by year, Raw Materials stood at $96.6 million in 2022, then fell by 20.21% to $77.0 million in 2023, then surged by 89.35% to $145.9 million in 2024, then climbed by 22.34% to $178.5 million in 2025, then grew by 7.4% to $191.7 million in 2026.
• Per Business Quant, the three latest PAHC Raw Materials figures stand at $191.7 million (Q1 2026), $178.5 million (Q4 2025), and $166.4 million (Q3 2025).